No records
|
8651025300 |
Renan Sukmawan |
dr. Renan Sukmawan, S.T., Sp.JP., Ph.D. |
Departemen Kardiologi dan Kedokteran Vaskular |
Kardiologi dan Kedokteran Vaskular (Sp-1) |
Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI) |
Sukmawan R., Hoetama E., Suridanda Danny S., Giantini A., Listiyaningsih E., Gilang Rejeki V., Aziz Alkatiri A., Firdaus I. |
Pharmacology Research and Perspectives |
|
Q1 |
|
|
12776781400 |
Astuti Giantini |
dr. Astuti Giantini, Sp.PK |
Departemen Patologi Klinik |
Patologi Klinik (Sp-1) |
Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI) |
Sukmawan R., Hoetama E., Suridanda Danny S., Giantini A., Listiyaningsih E., Gilang Rejeki V., Aziz Alkatiri A., Firdaus I. |
Pharmacology Research and Perspectives |
|
Q1 |
|
|
55796864700 |
Isman Firdaus |
dr. Isman Firdaus, Sp.J.P. |
Departemen Kardiologi dan Kedokteran Vaskular |
Kardiologi dan Kedokteran Vaskular (Sp-1) |
Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI) |
Sukmawan R., Hoetama E., Suridanda Danny S., Giantini A., Listiyaningsih E., Gilang Rejeki V., Aziz Alkatiri A., Firdaus I. |
Pharmacology Research and Perspectives |
|
Q1 |
|
|
No records
|
57193251655 |
Juferdy Kurniawan |
Dr.dr. Juferdy Kurniawan, Sp.P.D-KGEH. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Overall Survival of Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation (RFA) Treatment: a Retrospective Cohort Study from Two Referral Hospitals in Indonesia |
Sulaiman A.S., Gani R.A., Hasan I., Lesmana C.R.A., Kurniawan J., Jasirwan C.O.M., Kalista K.F., Nababan S.H.H., Aprilicia G., Lesmana L.A. |
Journal of Gastrointestinal Cancer |
|
Q3 |
|
|
8977683000 |
C. Rinaldi Lesmana |
Dr. dr. C. Rinaldi Lesmana, Sp.P.D.(KGEH). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Overall Survival of Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation (RFA) Treatment: a Retrospective Cohort Study from Two Referral Hospitals in Indonesia |
Sulaiman A.S., Gani R.A., Hasan I., Lesmana C.R.A., Kurniawan J., Jasirwan C.O.M., Kalista K.F., Nababan S.H.H., Aprilicia G., Lesmana L.A. |
Journal of Gastrointestinal Cancer |
|
Q3 |
|
|
12776850800 |
Irsan Hasan |
dr. Irsan Hasan, Sp.PD-KGEH. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
Overall Survival of Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation (RFA) Treatment: a Retrospective Cohort Study from Two Referral Hospitals in Indonesia |
Sulaiman A.S., Gani R.A., Hasan I., Lesmana C.R.A., Kurniawan J., Jasirwan C.O.M., Kalista K.F., Nababan S.H.H., Aprilicia G., Lesmana L.A. |
Journal of Gastrointestinal Cancer |
|
Q3 |
|
|
23495930300 |
Rino A. Gani |
Prof. Dr. dr. Rino A. Gani, SpPD-KGEH |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Overall Survival of Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation (RFA) Treatment: a Retrospective Cohort Study from Two Referral Hospitals in Indonesia |
Sulaiman A.S., Gani R.A., Hasan I., Lesmana C.R.A., Kurniawan J., Jasirwan C.O.M., Kalista K.F., Nababan S.H.H., Aprilicia G., Lesmana L.A. |
Journal of Gastrointestinal Cancer |
|
Q3 |
|
|
57216938482 |
Andri Sanityoso Sulaiman |
Dr. dr. Andri Sanityoso Sulaiman, Sp.PD. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
Overall Survival of Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation (RFA) Treatment: a Retrospective Cohort Study from Two Referral Hospitals in Indonesia |
Sulaiman A.S., Gani R.A., Hasan I., Lesmana C.R.A., Kurniawan J., Jasirwan C.O.M., Kalista K.F., Nababan S.H.H., Aprilicia G., Lesmana L.A. |
Journal of Gastrointestinal Cancer |
|
Q3 |
|
|